Exact Sciences
EXAS
#1107
Rank
โ‚น1.855 T
Marketcap
โ‚น9,722
Share price
0.00%
Change (1 day)
104.18%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -โ‚น15.95 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚น3.24 Billion. , an increase over its 2024 earnings that were of -โ‚น94.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น16.89 Billion-82.05%
2024 -โ‚น94.11 Billion435.05%
2023 -โ‚น17.59 Billion-69.18%
2022 -โ‚น57.07 Billion-25.77%
2021 -โ‚น76.89 Billion1.68%
2020 -โ‚น75.62 Billion271.17%
2019 -โ‚น20.38 Billion58.99%
2018 -โ‚น12.82 Billion20.89%
2017 -โ‚น10.6 Billion-30.95%
2016 -โ‚น15.36 Billion5.09%
2015 -โ‚น14.61 Billion57.24%
2014 -โ‚น9.29 Billion116.53%
2013 -โ‚น4.3 Billion
2011 -โ‚น2.68 Billion143.73%
2010 -โ‚น1.1 Billion27.85%
2009 -โ‚น0.86 Billion0.27%
2008 -โ‚น0.86 Billion-20.95%
2007 -โ‚น1.09 Billion-13.53%
2006 -โ‚น1.26 Billion-10.07%
2005 -โ‚น1.4 Billion-21.81%
2004 -โ‚น1.78 Billion-33.44%
2003 -โ‚น2.68 Billion-6.51%
2002 -โ‚น2.86 Billion17.95%
2001 -โ‚น2.43 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น721.71 B-4,373.95%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
โ‚น10.75 B-163.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น6.10 B-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น35.78 Billion 111.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น3.25 Billion-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA